These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours. Dimitriadis GK; Weickert MO; Randeva HS; Kaltsas G; Grossman A Endocr Relat Cancer; 2016 Sep; 23(9):R423-36. PubMed ID: 27461388 [TBL] [Abstract][Full Text] [Related]
52. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study. de Mestier L; Hentic O; Cros J; Walter T; Roquin G; Brixi H; Lombard-Bohas C; Hammel P; Diebold MD; Couvelard A; Ruszniewski P; Cadiot G Ann Intern Med; 2015 May; 162(10):682-9. PubMed ID: 25984844 [TBL] [Abstract][Full Text] [Related]
53. [Metastasizing, endocrine active pancreatic tumor with hormone conversion from gastrin to insulin]. Czermak H; Fortunat W; Schernthaner G Wien Med Wochenschr; 1987 Jun; 137(12):273-4. PubMed ID: 3303702 [No Abstract] [Full Text] [Related]
59. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer]. Hofsli E Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977 [TBL] [Abstract][Full Text] [Related]
60. Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor. Agarwal R; Szalkiewicz ER; Warner RR; Roayaie S; Hechtman JF; Zhu H; Kim MK Pancreas; 2014 Jan; 43(1):145-6. PubMed ID: 24326372 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]